Grants and Awards
Advance Biotech Grant Program
We understand the challenges emerging biotech companies face in the quest to push the next generation of drugs to market. This is why we have developed our AB Grant programs that we run on a regular basis in different regions of the world. These programs allow grant recipients to receive free products and services. Learn more
Biopharma Innovation Cup
Join the brightest students from all over the world for a week at the company headquarters. Learn from professionals, network, develop a business plan, and win a team prize! Learn more
Displaying Futures Award
With this award we recognize breakthrough ideas and entrepreneurial spirit in the field of Performance Materials. The winning teams receive extensive funding and mentorship from our experts to further explore and develop their idea. Learn more
Emanuel M. Lectureship
The Emanuel M. Lectureship was established in 1992 and is given in partnership with Technical University, Darmstadt, Germany. It recognizes globally renowned scientists for outstanding contributions to chemical and pharmaceutical research. Learn more
Global Grants for Medical Education
In order to promote advances in the field of medicine, we offer grants to independent medical education providers to design and deliver advanced medical training across the world enhancing medical practice for the ultimate benefit of patients. Learn more
2020 Research Grants
We are offering a series of research grants to stimulate innovative research in challenging areas of future importance. In 2020, grants of 100,000 EUR - 500,000 EUR per year for up to 3 years are availabe in the areas of: Drug discovery, Bioreactor design for cultured meat, Next generation machine learning, Pandemic preparedness / fighting new emerging viral infectious disease. Learn more
Latest News on Grants and AwardsView All News
Merck KGaA, Darmstadt, Germany today announced that Dr. Luciano Rossetti, MD, will be retiring as Global Head of Research & Development (R&D) for the Healthcare business sector.
Merck KGaA, Darmstadt, Germany today announced that it has entered into an out-licensing agreement with Novartis, for the development of M6495.
Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono, Inc. in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the publication of detailed results from the..